Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1993;2(5):385–389. doi: 10.1155/S0962935193000547

Prostaglandin cyclooxygenase products but not thromboxane A2 are involved in the pathogenesis of ewthromelalgia in thrombocythaemia

J J Michiels 1,✉, F J Zijlstra 2
PMCID: PMC2365430  PMID: 18475550

Abstract

Fluid of artificial blisters from erythromelalgic skin areas in primary thrombocythaemia contained a high amount of prostaglandin-E-like activity. Dazoxiben did not alleviate the erythromelalgia in patients with primary thrombocythaemia despite complete inhibition of platelet malondialdehyde and thromboxane B2 synthesis and no inhibition of prostaglandin-E-like material. During a 10-day dazoxiben treatment period, persistent erythromelalgia was associated with a significant shortened mean platelet life span of 3.2 days. During subsequent treatment with low dose acetylsalicylic acid daily complete relief of erythromelalgia was associated with inhibition of platelet prostaglandin endoperoxide production and correction of platelet mean life span to normal, 7.9 days. These observations indicate that prostaglandin E2, or another prostaglandin endoperoxide metabolite, is involved in the pathogenesisof erythromelalgia. The presented study does not give one single clue as to the origin (platelet, vessel wall or other) of the prostanoid, but very likely originates from platelets because a very low dose of acetylsalicylic acid (250 to 500 mg every other day), which irreversibly inhibits platelet cyclooxygenase, is highly effective in the prevention of erythromelalgia in thrombocythaemia.

Full Text

The Full Text of this article is available as a PDF (484.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aderem A. A., Albert K. A., Keum M. M., Wang J. K., Greengard P., Cohn Z. A. Stimulus-dependent myristoylation of a major substrate for protein kinase C. Nature. 1988 Mar 24;332(6162):362–364. doi: 10.1038/332362a0. [DOI] [PubMed] [Google Scholar]
  2. Aderem A. A., Cohen D. S., Wright S. D., Cohn Z. A. Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites. J Exp Med. 1986 Jul 1;164(1):165–179. doi: 10.1084/jem.164.1.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987 Apr 25;262(12):5592–5595. [PubMed] [Google Scholar]
  4. Amon U., von Stebut E., Dietz K. R., Bauer F. W., Wolff H. H. Pharmacological studies on the role of protein kinase C in signal transduction of human basophils. Int Arch Allergy Immunol. 1992;98(4):349–354. doi: 10.1159/000236210. [DOI] [PubMed] [Google Scholar]
  5. Burke L. A., Wilkinson J. R., Howell C. J., Lee T. H. Interactions of macrophages and monocytes with granulocytes in asthma. Eur Respir J Suppl. 1991 Apr;13:85s–90s. [PubMed] [Google Scholar]
  6. Cluzel M., Damon M., Chanez P., Bousquet J., Crastes de Paulet A., Michel F. B., Godard P. Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. J Allergy Clin Immunol. 1987 Aug;80(2):195–201. doi: 10.1016/0091-6749(87)90129-1. [DOI] [PubMed] [Google Scholar]
  7. Coffey R. G., Weakland L. L., Alberts V. A. Paradoxical stimulation and inhibition by protein kinase C modulating agents of lipopolysaccharide evoked production of tumour necrosis factor in human monocytes. Immunology. 1992 May;76(1):48–54. [PMC free article] [PubMed] [Google Scholar]
  8. Dieter P., Fitzke E. RO 31-8220 and RO 31-7549 show improved selectivity for protein kinase C over staurosporine in macrophages. Biochem Biophys Res Commun. 1991 Nov 27;181(1):396–401. doi: 10.1016/s0006-291x(05)81432-9. [DOI] [PubMed] [Google Scholar]
  9. Eden E., Turino G. M. Interleukin-1 secretion by human alveolar macrophages stimulated with endotoxin is augmented by recombinant immune (gamma) interferon. Am Rev Respir Dis. 1986 Mar;133(3):455–460. doi: 10.1164/arrd.1986.133.3.455. [DOI] [PubMed] [Google Scholar]
  10. Fels A. O., Cohn Z. A. The alveolar macrophage. J Appl Physiol (1985) 1986 Feb;60(2):353–369. doi: 10.1152/jappl.1986.60.2.353. [DOI] [PubMed] [Google Scholar]
  11. Fuller R. W. Pharmacological regulation of airway macrophage function. Clin Exp Allergy. 1991 Nov;21(6):651–654. doi: 10.1111/j.1365-2222.1991.tb03191.x. [DOI] [PubMed] [Google Scholar]
  12. Glaser K. B., Asmis R., Dennis E. A. Bacterial lipopolysaccharide priming of P388D1 macrophage-like cells for enhanced arachidonic acid metabolism. Platelet-activating factor receptor activation and regulation of phospholipase A2. J Biol Chem. 1990 May 25;265(15):8658–8664. [PubMed] [Google Scholar]
  13. Godard P., Chaintreuil J., Damon M., Coupe M., Flandre O., Crastes de Paulet A., Michel F. B. Functional assessment of alveolar macrophages: comparison of cells from asthmatics and normal subjects. J Allergy Clin Immunol. 1982 Aug;70(2):88–93. doi: 10.1016/0091-6749(82)90234-2. [DOI] [PubMed] [Google Scholar]
  14. Gomez-Cambronero J., Huang C. K., Bonak V. A., Wang E., Casnellie J. E., Shiraishi T., Sha'afi R. I. Tyrosine phosphorylation in human neutrophil. Biochem Biophys Res Commun. 1989 Aug 15;162(3):1478–1485. doi: 10.1016/0006-291x(89)90841-3. [DOI] [PubMed] [Google Scholar]
  15. Howell C. J., Pujol J. L., Crea A. E., Davidson R., Gearing A. J., Godard P., Lee T. H. Identification of an alveolar macrophage-derived activity in bronchial asthma that enhances leukotriene C4 generation by human eosinophils stimulated by ionophore A23187 as a granulocyte-macrophage colony-stimulating factor. Am Rev Respir Dis. 1989 Nov;140(5):1340–1347. doi: 10.1164/ajrccm/140.5.1340. [DOI] [PubMed] [Google Scholar]
  16. Joseph M., Tonnel A. B., Torpier G., Capron A., Arnoux B., Benveniste J. Involvement of immunoglobulin E in the secretory processes of alveolar macrophages from asthmatic patients. J Clin Invest. 1983 Feb;71(2):221–230. doi: 10.1172/JCI110762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Klausner R. D., Samelson L. E. T cell antigen receptor activation pathways: the tyrosine kinase connection. Cell. 1991 Mar 8;64(5):875–878. doi: 10.1016/0092-8674(91)90310-u. [DOI] [PubMed] [Google Scholar]
  18. Kusunoki T., Higashi H., Hosoi S., Hata D., Sugie K., Mayumi M., Mikawa H. Tyrosine phosphorylation and its possible role in superoxide production by human neutrophils stimulated with FMLP and IgG. Biochem Biophys Res Commun. 1992 Mar 16;183(2):789–796. doi: 10.1016/0006-291x(92)90552-v. [DOI] [PubMed] [Google Scholar]
  19. Murphy C. T., Westwick J. Selective inhibition of protein kinase C. Effect on platelet-activating-factor-induced platelet functional responses. Biochem J. 1992 Apr 1;283(Pt 1):159–164. doi: 10.1042/bj2830159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Offermanns S., Seifert R., Metzger J. W., Jung G., Lieberknecht A., Schmidt U., Schultz G. Lipopeptides are effective stimulators of tyrosine phosphorylation in human myeloid cells. Biochem J. 1992 Mar 1;282(Pt 2):551–557. doi: 10.1042/bj2820551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Thompson N. T., Tateson J. E., Randall R. W., Spacey G. D., Bonser R. W., Garland L. G. The temporal relationship between phospholipase activation, diradylglycerol formation and superoxide production in the human neutrophil. Biochem J. 1990 Oct 1;271(1):209–213. doi: 10.1042/bj2710209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Twomey B., Muid R. E., Nixon J. S., Sedgwick A. D., Wilkinson S. E., Dale M. M. The effect of new potent selective inhibitors of protein kinase C on the neutrophil respiratory burst. Biochem Biophys Res Commun. 1990 Sep 28;171(3):1087–1092. doi: 10.1016/0006-291x(90)90795-o. [DOI] [PubMed] [Google Scholar]
  23. Uings I. J., Thompson N. T., Randall R. W., Spacey G. D., Bonser R. W., Hudson A. T., Garland L. G. Tyrosine phosphorylation is involved in receptor coupling to phospholipase D but not phospholipase C in the human neutrophil. Biochem J. 1992 Feb 1;281(Pt 3):597–600. doi: 10.1042/bj2810597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wightman P. D., Raetz C. R. The activation of protein kinase C by biologically active lipid moieties of lipopolysaccharide. J Biol Chem. 1984 Aug 25;259(16):10048–10052. [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES